As of 2026-03-23, the Relative Valuation of Seres Therapeutics Inc (MCRB) is 12.88 USD. This relative valuation is based on P/E multiples. With the latest stock price at 8.50 USD, the upside of Seres Therapeutics Inc based on Relative Valuation is 51.5%.
The range of the Relative Valuation is 10.06 - 17.14 USD.
| Range | Selected | |
| Trailing P/E multiples | 21.7x - 27.2x | 24.3x |
| Forward P/E multiples | 21.0x - 25.6x | 21.8x |
| Fair Price | 10.06 - 17.14 | 12.88 |
| Upside | 18.4% - 101.7% | 51.5% |
| Date | P/E |
| 2026-03-19 | 14.43 |
| 2026-03-18 | 14.35 |
| 2026-03-17 | 14.91 |
| 2026-03-16 | 13.76 |
| 2026-03-13 | 13.71 |
| 2026-03-12 | 14.38 |
| 2026-03-11 | 14.19 |
| 2026-03-10 | 14.22 |
| 2026-03-09 | 14.81 |
| 2026-03-06 | 14.51 |
| 2026-03-05 | 15.13 |
| 2026-03-04 | 14.51 |
| 2026-03-03 | 13.98 |
| 2026-03-02 | 14.24 |
| 2026-02-27 | 13.89 |
| 2026-02-26 | 14.11 |
| 2026-02-25 | 14.12 |
| 2026-02-24 | 13.74 |
| 2026-02-23 | 12.96 |
| 2026-02-20 | 13.58 |
| 2026-02-19 | 13.89 |
| 2026-02-18 | 13.08 |
| 2026-02-17 | 13.16 |
| 2026-02-13 | 13.46 |
| 2026-02-12 | 13.06 |
| 2026-02-11 | 22.39 |
| 2026-02-10 | 22.74 |
| 2026-02-09 | 23.24 |
| 2026-02-06 | 22.18 |
| 2026-02-05 | 21.29 |
| 2026-02-04 | 21.66 |
| 2026-02-03 | 24.47 |
| 2026-02-02 | 24.07 |
| 2026-01-30 | 23.71 |
| 2026-01-29 | 24.28 |
| 2026-01-28 | 24.05 |
| 2026-01-27 | 24.53 |
| 2026-01-26 | 24.83 |
| 2026-01-23 | 23.91 |
| 2026-01-22 | 24.47 |
| 2026-01-21 | 23.91 |
| 2026-01-20 | 23.93 |
| 2026-01-16 | 25.36 |
| 2026-01-15 | 24.12 |
| 2026-01-14 | 25.55 |
| 2026-01-13 | 25.37 |
| 2026-01-12 | 25.17 |
| 2026-01-09 | 24.87 |
| 2026-01-08 | 24.55 |
| 2026-01-07 | 25.20 |